rs73467954
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The ENST00000360280.8(VPS13A):āc.5184T>Cā(p.Ser1728=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000685 in 1,613,886 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0037 ( 3 hom., cov: 32)
Exomes š: 0.00037 ( 2 hom. )
Consequence
VPS13A
ENST00000360280.8 synonymous
ENST00000360280.8 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.171
Genes affected
VPS13A (HGNC:1908): (vacuolar protein sorting 13 homolog A) The protein encoded by this gene may control steps in the cycling of proteins through the trans-Golgi network to endosomes, lysosomes and the plasma membrane. Mutations in this gene cause the autosomal recessive disorder, chorea-acanthocytosis. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.62).
BP6
Variant 9-77318462-T-C is Benign according to our data. Variant chr9-77318462-T-C is described in ClinVar as [Benign]. Clinvar id is 448866.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-77318462-T-C is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-0.171 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00366 (557/152308) while in subpopulation AFR AF= 0.0128 (530/41566). AF 95% confidence interval is 0.0119. There are 3 homozygotes in gnomad4. There are 268 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 3 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VPS13A | NM_033305.3 | c.5184T>C | p.Ser1728= | synonymous_variant | 41/72 | ENST00000360280.8 | NP_150648.2 | |
VPS13A | NM_001018037.2 | c.5067T>C | p.Ser1689= | synonymous_variant | 40/71 | NP_001018047.1 | ||
VPS13A | NM_015186.4 | c.5184T>C | p.Ser1728= | synonymous_variant | 41/69 | NP_056001.1 | ||
VPS13A | NM_001018038.3 | c.5184T>C | p.Ser1728= | synonymous_variant | 41/69 | NP_001018048.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VPS13A | ENST00000360280.8 | c.5184T>C | p.Ser1728= | synonymous_variant | 41/72 | 1 | NM_033305.3 | ENSP00000353422 | P4 |
Frequencies
GnomAD3 genomes AF: 0.00365 AC: 555AN: 152190Hom.: 3 Cov.: 32
GnomAD3 genomes
AF:
AC:
555
AN:
152190
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000903 AC: 226AN: 250194Hom.: 0 AF XY: 0.000651 AC XY: 88AN XY: 135278
GnomAD3 exomes
AF:
AC:
226
AN:
250194
Hom.:
AF XY:
AC XY:
88
AN XY:
135278
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000375 AC: 548AN: 1461578Hom.: 2 Cov.: 31 AF XY: 0.000337 AC XY: 245AN XY: 727094
GnomAD4 exome
AF:
AC:
548
AN:
1461578
Hom.:
Cov.:
31
AF XY:
AC XY:
245
AN XY:
727094
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00366 AC: 557AN: 152308Hom.: 3 Cov.: 32 AF XY: 0.00360 AC XY: 268AN XY: 74482
GnomAD4 genome
AF:
AC:
557
AN:
152308
Hom.:
Cov.:
32
AF XY:
AC XY:
268
AN XY:
74482
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Mar 29, 2017 | - - |
Chorea-acanthocytosis Benign:1
Likely benign, no assertion criteria provided | clinical testing | Natera, Inc. | Dec 06, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at